The Boston drugmaker (Nasdaq: VRTX) says it put more than two decades of work into developing and bringing the new medicine to market. Stuart Arbuckle, Vertex’s chief operating officer ...

BOSTON (AP) — BOSTON (AP) — Vertex Pharmaceuticals Inc. (VRTX) on Monday reported fourth-quarter profit of $913 million. The Boston-based company said it had net income of $3.50 per share.

That’s the opinion of top Vertex Pharmaceuticals executives and several market analysts about the Boston-based company’s painkiller Journavx, which the Food and Drug Administration approved on ...